Indium DTPA and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Indium DTPA and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111, In-111 DTPA
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium DTPA-Lithium ER
- Indium DTPA-Lithium Oral Solution
- Indium DTPA-Lithium Salts
- Indium DTPA-Lithium Syrup and Oral Solution
- Indium DTPA-Lithobid
- Indium DTPA-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Indium In-111 Pentetreotide
- Lithium Controlled-Release and Extended-Release Tablets-Indium Oxyquinoline
- Lithium Controlled-Release and Extended-Release Tablets-Indocid
- Lithium Controlled-Release and Extended-Release Tablets-Indocin
- Lithium Controlled-Release and Extended-Release Tablets-Indocin (Indomethacin Suppositories)
- Lithium Controlled-Release and Extended-Release Tablets-Indocin (Indomethacin Suspension)